# Bypass Surgery and CD133 Marrow Cell Injection for Treatment of Ischemic Heart Failure

> **NCT00462774** · PHASE2,PHASE3 · COMPLETED · sponsor: **German Heart Institute** · enrollment: 60 (actual)

## Conditions studied

- Coronary Artery Disease With Need for Bypass Surgery
- Myocardial Ischemia, Angina Pectoris
- Congestive Heart Failure
- Previous Myocardial Infarction

## Interventions

- **PROCEDURE:** Intramyocardial injection of autologous CD133+ marrow cells

## Key facts

- **NCT ID:** NCT00462774
- **Lead sponsor:** German Heart Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2013-01-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00462774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00462774, "Bypass Surgery and CD133 Marrow Cell Injection for Treatment of Ischemic Heart Failure". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00462774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*